Nathalie Landry

Nathalie Landry is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Chief Scientific Officer at PharmaJet since April 2023 and as a Board Member at InDevR, Inc. since January 2023. Previously, Nathalie held multiple leadership roles at Medicago from June 2007 to July 2021, including Executive Vice President of Scientific and Medical Affairs and Executive Vice President of Product Development. Nathalie Landry holds an MBA from Université Laval (1996-1999) and a M.Sc. in Microbiology-Immunology from Université Laval (1990-1991).